XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. XTL is a public company, traded on the NASDAQ (NASDAQ:XTLB) and the Tel-Aviv Stock Exchange (TASE:XTLB.TA)
Latest News
- 05/15/2026
XTL Biopharmaceuticals Ltd. (the “Company”) announced that it will hold an Extraordinary General Meeting of Shareholders
READ MORE >> - 07/03/2025
Annual and Extraordinary General Meeting
READ MORE >> - 11/19/2024
Form 6k 19.11.24
READ MORE >> - 06/11/2024
Extraordinary AGM meeting
READ MORE >> - 03/26/2024
XTL To Aquire The Social Proxy
READ MORE >>